The nasal microbiome of patients with cutaneous T-cell lymphoma (CTCL) remains unexplored despite growing evidence connecting nasal bacteria to skin health and disease. Nasal swabs from 45 patients with CTCL (40 with mycosis fungoides, 5 with Sézary syndrome) and 20 healthy controls from the same geographical region (Chicago Metropolitan Area, Chicago, IL) were analyzed using sequencing of 16S ribosomal RNA and gene amplicons. Nasal α-diversity did not differ between mycosis fungoides/Sézary syndrome and healthy controls (Shannon index, genus level, = 0.201), but distinct microbial communities were identified at the class (R = 0.104, = 0.023) and order (R = 0.0904, = 0.038) levels. Increased relative abundance of the genera , , , , and unclassified Clostridiales was associated with increased skin disease burden ( < 0.005, q < 0.05). Performed to accurately resolve nasal at the species level, gene amplicon sequencing revealed no significant differences between mycosis fungoides/Sézary syndrome and healthy controls. Although has been shown to worsen CTCL through its toxins, no increase in the relative abundance of this taxon was observed in nasal samples. Despite the lack of differences in the CTCL nasal microbiome was characterized by shifts in numerous other bacterial taxa. These data add to our understanding of the greater CTCL microbiome and provide context for comprehending nasal-skin and host‒tumor‒microbial relationships.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500465 | PMC |
http://dx.doi.org/10.1016/j.xjidi.2022.100132 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!